Your browser doesn't support javascript.
loading
Hypothalamic bile acid-TGR5 signaling protects from obesity.
Castellanos-Jankiewicz, Ashley; Guzmán-Quevedo, Omar; Fénelon, Valérie S; Zizzari, Philippe; Quarta, Carmelo; Bellocchio, Luigi; Tailleux, Anne; Charton, Julie; Fernandois, Daniela; Henricsson, Marcus; Piveteau, Catherine; Simon, Vincent; Allard, Camille; Quemener, Sandrine; Guinot, Valentine; Hennuyer, Nathalie; Perino, Alessia; Duveau, Alexia; Maitre, Marlène; Leste-Lasserre, Thierry; Clark, Samantha; Dupuy, Nathalie; Cannich, Astrid; Gonzales, Delphine; Deprez, Benoit; Mithieux, Gilles; Dombrowicz, David; Bäckhed, Fredrik; Prevot, Vincent; Marsicano, Giovanni; Staels, Bart; Schoonjans, Kristina; Cota, Daniela.
Afiliação
  • Castellanos-Jankiewicz A; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Guzmán-Quevedo O; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France; Laboratory of Neuronutrition and Metabolic Disorders, Instituto Tecnológico Superior de Tacámbaro, 61650 Tacámbaro, Michoacán, Mexico; Pós-Graduação em Neuropsiquiatria e Ciências do Comportamento, Universidade Fed
  • Fénelon VS; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Zizzari P; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Quarta C; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Bellocchio L; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Tailleux A; University of Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59019 Lille, France.
  • Charton J; University of Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, EGID, F-59000 Lille, France.
  • Fernandois D; University of Lille, INSERM, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, F-59000, Lille, France.
  • Henricsson M; The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 413 45 Gothenburg, Sweden.
  • Piveteau C; University of Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France.
  • Simon V; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Allard C; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Quemener S; University of Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59019 Lille, France.
  • Guinot V; University of Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59019 Lille, France.
  • Hennuyer N; University of Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59019 Lille, France.
  • Perino A; Institute of Bioengineering, Faculty of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland.
  • Duveau A; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Maitre M; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Leste-Lasserre T; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Clark S; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Dupuy N; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Cannich A; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Gonzales D; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Deprez B; University of Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, EGID, F-59000 Lille, France.
  • Mithieux G; INSERM U1213 Nutrition, Diabetes and the Brain, University of Lyon 1 Faculté de Médecine Lyon-Est, 69372 Lyon, France.
  • Dombrowicz D; University of Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59019 Lille, France.
  • Bäckhed F; The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 413 45 Gothenburg, Sweden; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, 2200 N Copenha
  • Prevot V; University of Lille, INSERM, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, F-59000, Lille, France.
  • Marsicano G; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Staels B; University of Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59019 Lille, France.
  • Schoonjans K; Institute of Bioengineering, Faculty of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland.
  • Cota D; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France. Electronic address: daniela.cota@inserm.fr.
Cell Metab ; 33(7): 1483-1492.e10, 2021 07 06.
Article em En | MEDLINE | ID: mdl-33887197
ABSTRACT
Bile acids (BAs) improve metabolism and exert anti-obesity effects through the activation of the Takeda G protein-coupled receptor 5 (TGR5) in peripheral tissues. TGR5 is also found in the brain hypothalamus, but whether hypothalamic BA signaling is implicated in body weight control and obesity pathophysiology remains unknown. Here we show that hypothalamic BA content is reduced in diet-induced obese mice. Central administration of BAs or a specific TGR5 agonist in these animals decreases body weight and fat mass by activating the sympathetic nervous system, thereby promoting negative energy balance. Conversely, genetic downregulation of hypothalamic TGR5 expression in the mediobasal hypothalamus favors the development of obesity and worsens established obesity by blunting sympathetic activity. Lastly, hypothalamic TGR5 signaling is required for the anti-obesity action of dietary BA supplementation. Together, these findings identify hypothalamic TGR5 signaling as a key mediator of a top-down neural mechanism that counteracts diet-induced obesity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácidos e Sais Biliares / Receptores Acoplados a Proteínas G / Obesidade Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cell Metab Assunto da revista: METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácidos e Sais Biliares / Receptores Acoplados a Proteínas G / Obesidade Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cell Metab Assunto da revista: METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França